| Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 8 |
| Opened positions | 1 |
| Closed positions | 1 |
| Increased positions | 1 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 3.91 bn |
| Total shares | 5.47 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Biotechnology Value Fund L P | 4.51 mm | $0.00 |
| BVF | 443.22 k | $1.77 bn |
| Suvretta Capital Management | 400.00 k | $1.66 bn |
| Tang Capital Management | 100.00 k | $414.00 mm |
| Susquehanna International | 16.58 k | $66.13 mm |
| MS Morgan Stanley | 367.00 | $1.52 mm |
| Rhumbline Advisers | 269.00 | $1.07 mm |
| Qube Research & Technologies | 16.00 | $64.00 k |
| Proequities | 0.00 | $0.00 |
